Intravenous System Access Devices Market Size & Competitors

The Intravenous System Access Devices Market is projected to reach USD 8.47 Billion in 2026. It is expected to continue growing at a CAGR of 5.26%, reaching USD 11.55 Billion by 2032.

Intravenous system access devices are foundational to modern care delivery, enabling medication administration, fluid resuscitation, parenteral nutrition, blood products, contrast delivery, chemotherapy, dialysis support, and critical care monitoring. The market spans peripheral intravenous catheters, midline catheters, peripherally inserted central catheters, central venous catheters, implanted ports, needleless connectors, securement devices, extension sets, dressings, and related vascular access accessories.

Demand is anchored by measurable clinical need: aging populations, the global burden of cancer and chronic disease, growth in surgical volumes, emergency care utilization, and the expansion of outpatient infusion and home-based therapy. At the same time, purchasing decisions are increasingly shaped by infection prevention, dwell-time performance, ease of insertion, compatibility with ultrasound and power injection, and compliance with recognized standards from bodies such as the CDC, FDA, ISO, and the Infusion Nurses Society.

For industry participants, the competitive center of gravity is shifting from commodity catheter supply to evidence-backed vascular access solutions that reduce complications, improve first-attempt success, support clinician workflow, and align with value-based healthcare priorities.

Transformative Shifts in the Intravenous Access Landscape

The intravenous system access devices landscape is being reshaped by the convergence of patient safety, site-of-care migration, and device innovation. Hospitals and ambulatory infusion centers are prioritizing technologies that help reduce catheter-related bloodstream infection, phlebitis, infiltration, occlusion, and dislodgement, which are well documented in clinical guidelines as drivers of avoidable cost and patient harm.

A major transformation is the movement toward ultrasound-guided and vessel-preserving access strategies, particularly for patients with difficult intravenous access, oncology patients, pediatric patients, and those requiring long-term therapy. This shift is supporting adoption of midlines, PICCs, implanted ports, securement systems, chlorhexidine-impregnated dressings where clinically appropriate, and closed or needleless access components designed to reduce manipulation risk.

The commercial model is also changing. Procurement teams increasingly evaluate total cost of care rather than unit price alone, giving an advantage to vendors that can document lower failure rates, fewer replacements, standardized training, and stronger supply continuity. Regulatory scrutiny, sustainability expectations, and post-market surveillance requirements are further pushing manufacturers toward higher-quality materials, transparent clinical evidence, and resilient global supply chains.

Cumulative Impact of Artificial Intelligence on IV Access

Artificial intelligence is beginning to influence intravenous access through decision support, workflow optimization, and surveillance rather than replacing clinical judgment. In vascular access, AI-enabled imaging and analytics can support vein assessment, difficult-access prediction, device selection, and escalation pathways for ultrasound-guided placement or specialist vascular access teams.

In hospitals, machine learning can strengthen infection prevention programs by flagging central line dwell time, dressing-change compliance, blood culture patterns, and unit-level risk signals. AI can also improve inventory forecasting for high-use consumables such as PIVCs, securement devices, connectors, and infusion accessories, reducing stockouts while limiting waste.

The cumulative impact will depend on validation, interoperability, and governance. AI tools connected to intravenous access workflows must demonstrate clinical utility, cybersecurity resilience, bias mitigation, and compliance with software-as-a-medical-device expectations where applicable. Leaders that combine device innovation with validated analytics, electronic health record integration, and clinician-centered training are positioned to create measurable improvements in first-stick success, complication reduction, and operational efficiency.

Key Regional Insights Across Global IV Access Markets

Asia-Pacific is one of the most dynamic regions for intravenous system access devices, supported by hospital infrastructure expansion, rising surgical and oncology care demand, growth in private healthcare networks, and broader insurance coverage in several markets. China, India, Japan, South Korea, Australia, and ASEAN economies are increasing adoption of ultrasound-guided access, safety-engineered devices, and standardized infusion practices, though price sensitivity and uneven rural access remain important constraints.

North America remains a high-value environment due to advanced hospital protocols, strong infection surveillance, outpatient infusion growth, and widespread use of vascular access teams. The United States and Canada emphasize evidence-based central line maintenance, product standardization, and compliance with CDC-aligned infection prevention practices, creating demand for premium catheters, securement, antimicrobial or antithrombogenic features where clinically supported, and digital workflow tools.

Latin America is advancing through public hospital modernization, private provider investment, and expanding chronic disease treatment capacity. Brazil and Mexico are key demand centers, while broader regional growth is influenced by reimbursement variability, tender-based procurement, and the need for cost-effective devices that support safe insertion and maintenance.

Europe is shaped by mature clinical practice, the EU Medical Device Regulation, sustainability requirements, and strong emphasis on patient safety. Germany, France, Italy, Spain, and the United Kingdom show consistent demand for high-quality vascular access products, while procurement increasingly considers clinical evidence, traceability, and lifecycle value.

The Middle East, led by GCC healthcare investment, is adopting advanced infusion therapy infrastructure, specialty oncology centers, and international accreditation standards. Africa presents a long-term access opportunity, with demand tied to essential hospital supplies, maternal and emergency care, infection prevention capacity, and affordable products suited to diverse care environments.

Key Group Insights for IV Access Device Adoption

ASEAN markets are benefiting from expanding hospital capacity, medical tourism in selected countries, and growing treatment volumes for chronic disease, but adoption patterns vary widely between advanced urban hospitals and resource-constrained public systems. Suppliers that balance affordability with training, infection-control support, and reliable distribution are best positioned.

The GCC is characterized by significant healthcare infrastructure investment, specialty care expansion, and demand for internationally benchmarked clinical practices. Hospitals in Saudi Arabia, the United Arab Emirates, Qatar, Kuwait, Bahrain, and Oman are receptive to premium vascular access solutions when supported by clinical evidence, education, and service reliability.

The European Union is defined by harmonized regulatory expectations under the MDR, sophisticated procurement systems, and strong patient safety requirements. Market access depends on robust technical documentation, post-market clinical follow-up, and the ability to demonstrate quality, traceability, and value across health systems.

BRICS countries create scale-driven opportunity due to large patient populations, rising healthcare expenditure, and expanding oncology, dialysis, surgical, and emergency care needs. However, purchasing behavior can be highly localized, with domestic manufacturing policies, tender structures, and affordability shaping product mix.

G7 markets represent premium demand for advanced intravenous access devices, clinical evidence, infection prevention, and digital integration. NATO countries, many of which overlap with G7 and EU systems, add resilience and supply security considerations, making trusted sourcing, manufacturing redundancy, and regulatory compliance increasingly strategic.

Key Country Insights in Intravenous Access Devices

The United States leads in advanced vascular access practice, driven by large hospital networks, outpatient infusion expansion, infection surveillance, and rapid adoption of technologies that improve safety and workflow. Canada shows similar clinical priorities with centralized procurement dynamics and strong emphasis on quality and standardization. Mexico combines public-sector price sensitivity with private hospital demand for modern infusion and vascular access systems, while Brazil anchors Latin American demand through large patient volumes and expanding specialty care.

In Europe, the United Kingdom emphasizes guideline-driven practice, hospital efficiency, and National Health Service value assessment. Germany is a major market for high-quality medical devices and engineering-led product standards. France supports strong hospital procurement and infection prevention priorities, while Italy and Spain show sustained demand across public and private care networks. Russia remains a sizable market, though access is shaped by localization, procurement rules, and geopolitical supply considerations.

In Asia-Pacific, China is a scale market supported by hospital modernization and domestic manufacturing growth. India is expanding rapidly as tertiary care, oncology, dialysis, and emergency services grow, but affordability remains central. Japan prioritizes quality, safety, and aging-population care needs, while Australia maintains high clinical standards and structured procurement. South Korea combines advanced hospitals, digital health readiness, and strong medtech capabilities, supporting adoption of premium and technology-enabled IV access solutions.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize clinically differentiated products that address the most persistent sources of IV therapy failure: difficult insertion, catheter dislodgement, occlusion, phlebitis, infiltration, and catheter-related infection. Evidence generation should include real-world outcomes, health economic analysis, and usability data across emergency, intensive care, oncology, pediatrics, and home infusion settings.

Manufacturers should strengthen portfolios beyond standalone catheters by integrating securement, dressings, connectors, flushing protocols, ultrasound compatibility, and digital documentation support. This systems-based approach aligns with how hospitals manage vascular access risk and can support value-based contracting.

Commercial teams should localize market strategies. Premium markets require clinical evidence, regulatory readiness, and digital integration, while emerging markets require affordability, training, distribution reliability, and infection prevention education. Across all markets, supply chain resilience, materials transparency, cybersecurity for connected tools, and post-market surveillance should be treated as board-level priorities.

Research Methodology for IV Access Market Intelligence

This executive summary is built on a structured research methodology combining secondary research, regulatory review, clinical guideline analysis, product intelligence, and market triangulation. Sources considered include public health guidance, medical device regulatory frameworks, hospital infection prevention standards, peer-reviewed vascular access literature, procurement trends, and publicly available product documentation.

The research framework evaluates demand by device type, care setting, application, end user, region, and country. Qualitative insights are validated through comparison across multiple evidence categories, including clinical need, installed healthcare capacity, reimbursement environment, regulatory requirements, supply chain factors, and adoption barriers.

Data interpretation emphasizes verified and observable market drivers rather than speculative claims. Findings are normalized across mature and emerging markets to identify actionable patterns in product adoption, competitive positioning, and strategic opportunity for intravenous system access device stakeholders.

Conclusion: The Future of Intravenous System Access Devices

Intravenous system access devices will remain essential to acute, chronic, and ambulatory care as healthcare systems manage growing treatment intensity, aging populations, oncology demand, and complex medication delivery. The market is moving toward safer, longer-lasting, evidence-supported, and workflow-friendly solutions that reduce preventable complications and improve clinician efficiency.

Artificial intelligence, ultrasound guidance, infection surveillance, and integrated vascular access platforms will increasingly shape competitive advantage, but adoption will depend on clinical validation, regulatory compliance, and measurable value. Organizations that combine product quality, education, supply reliability, and data-backed outcomes will be best positioned to lead across both mature and emerging markets.

Additional Product Information:

Purchase of this report includes 1 year online access with quarterly updates.
This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

1. Preface

1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders

2. Research Methodology

2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations

3. Executive Summary

3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap

4. Market Overview

4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy

5. Market Insights

5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Intravenous System Access Devices Market, by Device Type

7.1. Introduction
7.2. Central Intravenous Access
7.2.1. Implantable Devices
7.2.2. Non-tunneled Catheters
7.2.3. Peripherally Inserted Central Catheter
7.2.4. Tunneled & Cuffed Central Catheter
7.3. Peripheral Intravenous Access
7.3.1. Midline Catheter
7.3.2. PIV Catheter

8. Intravenous System Access Devices Market, by Product Component

8.1. Introduction
8.2. Catheters
8.3. IV Access Accessories
8.4. Securement Devices
8.5. Dressing & Infection Prevention Products

9. Intravenous System Access Devices Market, by Material Type

9.1. Introduction
9.2. Polyurethane Catheters
9.3. Silicone Catheters
9.4. Teflon (PTFE) Catheters
9.5. Antimicrobial-coated Catheters

10. Intravenous System Access Devices Market, by Lumen Type

10.1. Introduction
10.2. Single-Lumen Devices
10.3. Double-Lumen Devices
10.4. Multi-Lumen Devices

11. Intravenous System Access Devices Market, by Technology

11.1. Introduction
11.2. Conventional IV Access Devices
11.3. Safety-Engineered Devices
11.4. Infection-Control Devices

12. Intravenous System Access Devices Market, by Application

12.1. Introduction
12.2. Blood Transfusion
12.3. Diagnostic Testing
12.4. Drug Administration
12.5. Fluid & Nutritional Support

13. Intravenous System Access Devices Market, by Region

13.1. Asia-Pacific
13.2. Europe
13.3. North America
13.4. Latin America
13.5. Africa
13.6. Middle East

14. Intravenous System Access Devices Market, by Group

14.1. NATO
14.2. G7
14.3. BRICS
14.4. European Union
14.5. ASEAN
14.6. GCC

15. Intravenous System Access Devices Market, by Country

15.1. China
15.2. United States
15.3. Japan
15.4. India
15.5. Germany
15.6. United Kingdom
15.7. Australia
15.8. France
15.9. South Korea
15.10. Italy
15.11. Canada
15.12. Russia
15.13. Brazil
15.14. Mexico
15.15. Spain

16. Competitive Landscape

16.1. Market Share Analysis, 2025
16.2. FPNV Positioning Matrix, 2025
16.3. Market Concentration Analysis, 2025
16.3.1. Concentration Ratio (CR)
16.3.2. Herfindahl Hirschman Index (HHI)
16.4. Recent Developments & Impact Analysis, 2025
16.5. Product Portfolio Analysis, 2025
16.6. Benchmarking Analysis, 2025

17. Company Profiles

17.1. 3M Company
17.2. AngioDynamics, Inc.
17.3. Argon Medical Devices, Inc.
17.4. B. Braun Melsungen AG
17.5. Baxter International Inc.
17.6. Becton, Dickinson and Company
17.7. Cook Medical
17.8. Fresenius Medical Care AG & Co. KGaA
17.9. Guangdong Baihe Medical Technology Co., Ltd.
17.10. Hospira, Inc.
17.11. ICU Medical, Inc.
17.12. Insulet Corporation
17.13. Jiangsu Kangjin Medical Instrument Co., Ltd.
17.14. Medtronic plc
17.15. Merit Medical Systems, Inc.
17.16. Nipro Corporation
17.17. Poly Medicure Limited
17.18. Romsons Group Private Limited
17.19. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
17.20. Smiths Medical, Inc.
17.21. Teleflex Incorporated
17.22. Terumo Corporation
17.23. Vygon SA

List of Figures

FIGURE 1. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PRODUCT COMPONENT, 2025 VS 2032 (%)
FIGURE 9. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PRODUCT COMPONENT, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2025 VS 2032 (%)
FIGURE 11. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY LUMEN TYPE, 2025 VS 2032 (%)
FIGURE 13. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY LUMEN TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
FIGURE 15. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 17. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 19. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 21. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 23. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 25. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025

List of Tables

TABLE 1. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL CENTRAL INTRAVENOUS ACCESS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL CENTRAL INTRAVENOUS ACCESS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL CENTRAL INTRAVENOUS ACCESS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL IMPLANTABLE DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL IMPLANTABLE DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL IMPLANTABLE DEVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL NON-TUNNELED CATHETERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL NON-TUNNELED CATHETERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL NON-TUNNELED CATHETERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL TUNNELED & CUFFED CENTRAL CATHETER MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL TUNNELED & CUFFED CENTRAL CATHETER MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL TUNNELED & CUFFED CENTRAL CATHETER MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL PERIPHERAL INTRAVENOUS ACCESS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL PERIPHERAL INTRAVENOUS ACCESS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL PERIPHERAL INTRAVENOUS ACCESS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL MIDLINE CATHETER MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL MIDLINE CATHETER MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL MIDLINE CATHETER MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL PIV CATHETER MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL PIV CATHETER MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL PIV CATHETER MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PRODUCT COMPONENT, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL CATHETERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL CATHETERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL CATHETERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL IV ACCESS ACCESSORIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL IV ACCESS ACCESSORIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL IV ACCESS ACCESSORIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL SECUREMENT DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL SECUREMENT DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL SECUREMENT DEVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL DRESSING & INFECTION PREVENTION PRODUCTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL DRESSING & INFECTION PREVENTION PRODUCTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL DRESSING & INFECTION PREVENTION PRODUCTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL POLYURETHANE CATHETERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL POLYURETHANE CATHETERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL POLYURETHANE CATHETERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL SILICONE CATHETERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL SILICONE CATHETERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL SILICONE CATHETERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL TEFLON (PTFE) CATHETERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL TEFLON (PTFE) CATHETERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL TEFLON (PTFE) CATHETERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL ANTIMICROBIAL-COATED CATHETERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL ANTIMICROBIAL-COATED CATHETERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL ANTIMICROBIAL-COATED CATHETERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY LUMEN TYPE, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL SINGLE-LUMEN DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL SINGLE-LUMEN DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL SINGLE-LUMEN DEVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL DOUBLE-LUMEN DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL DOUBLE-LUMEN DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL DOUBLE-LUMEN DEVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL MULTI-LUMEN DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL MULTI-LUMEN DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL MULTI-LUMEN DEVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL CONVENTIONAL IV ACCESS DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL CONVENTIONAL IV ACCESS DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL CONVENTIONAL IV ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL SAFETY-ENGINEERED DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL SAFETY-ENGINEERED DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL SAFETY-ENGINEERED DEVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL INFECTION-CONTROL DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL INFECTION-CONTROL DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL INFECTION-CONTROL DEVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL BLOOD TRANSFUSION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL BLOOD TRANSFUSION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL BLOOD TRANSFUSION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL DIAGNOSTIC TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL DIAGNOSTIC TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL DIAGNOSTIC TESTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL DRUG ADMINISTRATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL DRUG ADMINISTRATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL DRUG ADMINISTRATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 84. GLOBAL FLUID & NUTRITIONAL SUPPORT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 85. GLOBAL FLUID & NUTRITIONAL SUPPORT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 86. GLOBAL FLUID & NUTRITIONAL SUPPORT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 87. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 88. ASIA-PACIFIC INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 89. ASIA-PACIFIC INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 90. ASIA-PACIFIC INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2017-2032 (USD MILLION)
TABLE 91. ASIA-PACIFIC INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2017-2032 (USD MILLION)
TABLE 92. ASIA-PACIFIC INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PRODUCT COMPONENT, 2017-2032 (USD MILLION)
TABLE 93. ASIA-PACIFIC INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 94. ASIA-PACIFIC INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY LUMEN TYPE, 2017-2032 (USD MILLION)
TABLE 95. ASIA-PACIFIC INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 96. ASIA-PACIFIC INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 97. EUROPE INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 98. EUROPE INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 99. EUROPE INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2017-2032 (USD MILLION)
TABLE 100. EUROPE INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2017-2032 (USD MILLION)
TABLE 101. EUROPE INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PRODUCT COMPONENT, 2017-2032 (USD MILLION)
TABLE 102. EUROPE INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 103. EUROPE INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY LUMEN TYPE, 2017-2032 (USD MILLION)
TABLE 104. EUROPE INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 105. EUROPE INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 106. NORTH AMERICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 107. NORTH AMERICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 108. NORTH AMERICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2017-2032 (USD MILLION)
TABLE 109. NORTH AMERICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2017-2032 (USD MILLION)
TABLE 110. NORTH AMERICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PRODUCT COMPONENT, 2017-2032 (USD MILLION)
TABLE 111. NORTH AMERICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 112. NORTH AMERICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY LUMEN TYPE, 2017-2032 (USD MILLION)
TABLE 113. NORTH AMERICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 114. NORTH AMERICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 115. LATIN AMERICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 116. LATIN AMERICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 117. LATIN AMERICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2017-2032 (USD MILLION)
TABLE 118. LATIN AMERICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2017-2032 (USD MILLION)
TABLE 119. LATIN AMERICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PRODUCT COMPONENT, 2017-2032 (USD MILLION)
TABLE 120. LATIN AMERICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 121. LATIN AMERICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY LUMEN TYPE, 2017-2032 (USD MILLION)
TABLE 122. LATIN AMERICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 123. LATIN AMERICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 124. AFRICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 125. AFRICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 126. AFRICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2017-2032 (USD MILLION)
TABLE 127. AFRICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2017-2032 (USD MILLION)
TABLE 128. AFRICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PRODUCT COMPONENT, 2017-2032 (USD MILLION)
TABLE 129. AFRICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 130. AFRICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY LUMEN TYPE, 2017-2032 (USD MILLION)
TABLE 131. AFRICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 132. AFRICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 133. MIDDLE EAST INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 134. MIDDLE EAST INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 135. MIDDLE EAST INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2017-2032 (USD MILLION)
TABLE 136. MIDDLE EAST INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2017-2032 (USD MILLION)
TABLE 137. MIDDLE EAST INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PRODUCT COMPONENT, 2017-2032 (USD MILLION)
TABLE 138. MIDDLE EAST INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 139. MIDDLE EAST INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY LUMEN TYPE, 2017-2032 (USD MILLION)
TABLE 140. MIDDLE EAST INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 141. MIDDLE EAST INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 142. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 143. NATO INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 144. NATO INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 145. NATO INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2017-2032 (USD MILLION)
TABLE 146. NATO INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2017-2032 (USD MILLION)
TABLE 147. NATO INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PRODUCT COMPONENT, 2017-2032 (USD MILLION)
TABLE 148. NATO INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 149. NATO INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY LUMEN TYPE, 2017-2032 (USD MILLION)
TABLE 150. NATO INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 151. NATO INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 152. G7 INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 153. G7 INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 154. G7 INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2017-2032 (USD MILLION)
TABLE 155. G7 INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2017-2032 (USD MILLION)
TABLE 156. G7 INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PRODUCT COMPONENT, 2017-2032 (USD MILLION)
TABLE 157. G7 INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 158. G7 INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY LUMEN TYPE, 2017-2032 (USD MILLION)
TABLE 159. G7 INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 160. G7 INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 161. BRICS INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 162. BRICS INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 163. BRICS INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2017-2032 (USD MILLION)
TABLE 164. BRICS INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2017-2032 (USD MILLION)
TABLE 165. BRICS INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PRODUCT COMPONENT, 2017-2032 (USD MILLION)
TABLE 166. BRICS INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 167. BRICS INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY LUMEN TYPE, 2017-2032 (USD MILLION)
TABLE 168. BRICS INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 169. BRICS INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 170. EUROPEAN UNION INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 171. EUROPEAN UNION INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 172. EUROPEAN UNION INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2017-2032 (USD MILLION)
TABLE 173. EUROPEAN UNION INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2017-2032 (USD MILLION)
TABLE 174. EUROPEAN UNION INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PRODUCT COMPONENT, 2017-2032 (USD MILLION)
TABLE 175. EUROPEAN UNION INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 176. EUROPEAN UNION INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY LUMEN TYPE, 2017-2032 (USD MILLION)
TABLE 177. EUROPEAN UNION INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 178. EUROPEAN UNION INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 179. ASEAN INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 180. ASEAN INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 181. ASEAN INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2017-2032 (USD MILLION)
TABLE 182. ASEAN INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2017-2032 (USD MILLION)
TABLE 183. ASEAN INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PRODUCT COMPONENT, 2017-2032 (USD MILLION)
TABLE 184. ASEAN INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 185. ASEAN INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY LUMEN TYPE, 2017-2032 (USD MILLION)
TABLE 186. ASEAN INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 187. ASEAN INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 188. GCC INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 189. GCC INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 190. GCC INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2017-2032 (USD MILLION)
TABLE 191. GCC INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2017-2032 (USD MILLION)
TABLE 192. GCC INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PRODUCT COMPONENT, 2017-2032 (USD MILLION)
TABLE 193. GCC INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 194. GCC INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY LUMEN TYPE, 2017-2032 (USD MILLION)
TABLE 195. GCC INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 196. GCC INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 197. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 198. CHINA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 199. CHINA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 200. CHINA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2017-2032 (USD MILLION)
TABLE 201. CHINA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2017-2032 (USD MILLION)
TABLE 202. CHINA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PRODUCT COMPONENT, 2017-2032 (USD MILLION)
TABLE 203. CHINA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 204. CHINA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY LUMEN TYPE, 2017-2032 (USD MILLION)
TABLE 205. CHINA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 206. CHINA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 207. UNITED STATES INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 208. UNITED STATES INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 209. UNITED STATES INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2017-2032 (USD MILLION)
TABLE 210. UNITED STATES INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2017-2032 (USD MILLION)
TABLE 211. UNITED STATES INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PRODUCT COMPONENT, 2017-2032 (USD MILLION)
TABLE 212. UNITED STATES INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 213. UNITED STATES INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY LUMEN TYPE, 2017-2032 (USD MILLION)
TABLE 214. UNITED STATES INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 215. UNITED STATES INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 216. JAPAN INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 217. JAPAN INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 218. JAPAN INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2017-2032 (USD MILLION)
TABLE 219. JAPAN INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2017-2032 (USD MILLION)
TABLE 220. JAPAN INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PRODUCT COMPONENT, 2017-2032 (USD MILLION)
TABLE 221. JAPAN INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 222. JAPAN INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY LUMEN TYPE, 2017-2032 (USD MILLION)
TABLE 223. JAPAN INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 224. JAPAN INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 225. INDIA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 226. INDIA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 227. INDIA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2017-2032 (USD MILLION)
TABLE 228. INDIA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2017-2032 (USD MILLION)
TABLE 229. INDIA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PRODUCT COMPONENT, 2017-2032 (USD MILLION)
TABLE 230. INDIA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 231. INDIA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY LUMEN TYPE, 2017-2032 (USD MILLION)
TABLE 232. INDIA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 233. INDIA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 234. GERMANY INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 235. GERMANY INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 236. GERMANY INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2017-2032 (USD MILLION)
TABLE 237. GERMANY INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2017-2032 (USD MILLION)
TABLE 238. GERMANY INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PRODUCT COMPONENT, 2017-2032 (USD MILLION)
TABLE 239. GERMANY INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 240. GERMANY INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY LUMEN TYPE, 2017-2032 (USD MILLION)
TABLE 241. GERMANY INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 242. GERMANY INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 243. UNITED KINGDOM INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 244. UNITED KINGDOM INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 245. UNITED KINGDOM INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2017-2032 (USD MILLION)
TABLE 246. UNITED KINGDOM INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2017-2032 (USD MILLION)
TABLE 247. UNITED KINGDOM INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PRODUCT COMPONENT, 2017-2032 (USD MILLION)
TABLE 248. UNITED KINGDOM INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 249. UNITED KINGDOM INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY LUMEN TYPE, 2017-2032 (USD MILLION)
TABLE 250. UNITED KINGDOM INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 251. UNITED KINGDOM INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 252. AUSTRALIA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 253. AUSTRALIA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 254. AUSTRALIA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2017-2032 (USD MILLION)
TABLE 255. AUSTRALIA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2017-2032 (USD MILLION)
TABLE 256. AUSTRALIA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PRODUCT COMPONENT, 2017-2032 (USD MILLION)
TABLE 257. AUSTRALIA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 258. AUSTRALIA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY LUMEN TYPE, 2017-2032 (USD MILLION)
TABLE 259. AUSTRALIA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 260. AUSTRALIA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 261. FRANCE INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 262. FRANCE INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 263. FRANCE INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2017-2032 (USD MILLION)
TABLE 264. FRANCE INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2017-2032 (USD MILLION)
TABLE 265. FRANCE INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PRODUCT COMPONENT, 2017-2032 (USD MILLION)
TABLE 266. FRANCE INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 267. FRANCE INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY LUMEN TYPE, 2017-2032 (USD MILLION)
TABLE 268. FRANCE INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 269. FRANCE INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 270. SOUTH KOREA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 271. SOUTH KOREA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 272. SOUTH KOREA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2017-2032 (USD MILLION)
TABLE 273. SOUTH KOREA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2017-2032 (USD MILLION)
TABLE 274. SOUTH KOREA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PRODUCT COMPONENT, 2017-2032 (USD MILLION)
TABLE 275. SOUTH KOREA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 276. SOUTH KOREA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY LUMEN TYPE, 2017-2032 (USD MILLION)
TABLE 277. SOUTH KOREA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 278. SOUTH KOREA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 279. ITALY INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 280. ITALY INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 281. ITALY INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2017-2032 (USD MILLION)
TABLE 282. ITALY INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2017-2032 (USD MILLION)
TABLE 283. ITALY INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PRODUCT COMPONENT, 2017-2032 (USD MILLION)
TABLE 284. ITALY INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 285. ITALY INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY LUMEN TYPE, 2017-2032 (USD MILLION)
TABLE 286. ITALY INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 287. ITALY INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 288. CANADA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 289. CANADA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 290. CANADA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2017-2032 (USD MILLION)
TABLE 291. CANADA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2017-2032 (USD MILLION)
TABLE 292. CANADA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PRODUCT COMPONENT, 2017-2032 (USD MILLION)
TABLE 293. CANADA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 294. CANADA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY LUMEN TYPE, 2017-2032 (USD MILLION)
TABLE 295. CANADA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 296. CANADA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 297. RUSSIA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 298. RUSSIA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 299. RUSSIA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2017-2032 (USD MILLION)
TABLE 300. RUSSIA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2017-2032 (USD MILLION)
TABLE 301. RUSSIA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PRODUCT COMPONENT, 2017-2032 (USD MILLION)
TABLE 302. RUSSIA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 303. RUSSIA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY LUMEN TYPE, 2017-2032 (USD MILLION)
TABLE 304. RUSSIA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 305. RUSSIA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 306. BRAZIL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 307. BRAZIL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 308. BRAZIL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2017-2032 (USD MILLION)
TABLE 309. BRAZIL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2017-2032 (USD MILLION)
TABLE 310. BRAZIL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PRODUCT COMPONENT, 2017-2032 (USD MILLION)
TABLE 311. BRAZIL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 312. BRAZIL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY LUMEN TYPE, 2017-2032 (USD MILLION)
TABLE 313. BRAZIL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 314. BRAZIL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 315. MEXICO INTRAVENOUS SYSTEM ACCESS

Companies Mentioned

3M Company
AngioDynamics, Inc.
Argon Medical Devices, Inc.
B. Braun Melsungen AG
Baxter International Inc.
Becton, Dickinson and Company
Cook Medical
Fresenius Medical Care AG & Co. KGaA
Guangdong Baihe Medical Technology Co., Ltd.
Hospira, Inc.
ICU Medical, Inc.
Insulet Corporation
Jiangsu Kangjin Medical Instrument Co., Ltd.
Medtronic plc
Merit Medical Systems, Inc.
Nipro Corporation
Poly Medicure Limited
Romsons Group Private Limited
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
Smiths Medical, Inc.
Teleflex Incorporated
Terumo Corporation
Vygon SA

Table Information

Report Attribute	Details
No. of Pages	182
Published	August 2026
Forecast Period	2026 - 2032
Estimated Market Value ( USD ) in 2026	$ 8.47 Billion
Forecasted Market Value ( USD ) by 2032	$ 11.55 Billion
Compound Annual Growth Rate	5.2%
Regions Covered	Global
No. of Companies Mentioned	23

License	Format	Properties	Price
1 - 5 USER LICENSE PDF, Excel and Online Access		This is a 1-5 user license, allowing up to five users have access to the product.	€3156EUR$3,545USD£2,710GBP €3507EUR$3,939USD£3,012GBP
ENTERPRISE LICENSE PDF, Excel and Online Access		This is an enterprise license, allowing all employees within your organization access to the product.	€4775EUR$5,363USD£4,100GBP €5306EUR$5,959USD£4,556GBP

Intravenous System Access Devices Market - Global Forecast 2026-2032

Transformative Shifts in the Intravenous Access Landscape

Cumulative Impact of Artificial Intelligence on IV Access

Key Regional Insights Across Global IV Access Markets

Key Group Insights for IV Access Device Adoption

Key Country Insights in Intravenous Access Devices

Actionable Recommendations for Industry Leaders

Research Methodology for IV Access Market Intelligence

Conclusion: The Future of Intravenous System Access Devices

Table of Contents

Companies Mentioned

Table Information

Transformative Shifts in the Intravenous Access Landscape

Cumulative Impact of Artificial Intelligence on IV Access

Key Regional Insights Across Global IV Access Markets

Key Group Insights for IV Access Device Adoption

Key Country Insights in Intravenous Access Devices

Actionable Recommendations for Industry Leaders

Research Methodology for IV Access Market Intelligence

Conclusion: The Future of Intravenous System Access Devices

Table of Contents

Companies Mentioned

Table Information

Related Topics

Related Reports

IV Tubing Sets & Accessories Market - Global Forecast 2026-2032

Cannula Market - Global Forecast 2026-2032

Intravenous Therapy and Vein Access Devices Market Report 2026

Global Intravenous (IV) Equipment Market Outlook, 2031

South America Intravenous (IV) Equipment Market Outlook, 2031

About the Intravenous System Access Device Market